Literature DB >> 18781677

Levodopa-related motor complications--phenomenology.

Susan H Fox1, Anthony E Lang.   

Abstract

Long term levodopa therapy in Parkinson's disease (PD) results in a range of problems. These include fluctuations in FD symptoms termed motor fluctuations, as well as non-motor symptoms, termed non-motor fluctuations. Here we review the phenomenology and methods of assessing these levodopa-related complications. (c) 2008 Movement Disorder Society.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18781677     DOI： 10.1002/mds.22021

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  25 in total

Review 1.  Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.

Authors:  Lisa M Kosloski; Duy M Ha; Jessica A L Hutter; David K Stone; Michael R Pichler; Ashley D Reynolds; Howard E Gendelman; R Lee Mosley
Journal:  J Neurochem       Date:  2010-05-26       Impact factor: 5.372

Review 2.  Targeting nicotinic receptors for Parkinson's disease therapy.

Authors:  Maryka Quik; Tanuja Bordia; Luping Huang; Xiomara Perez
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

3.  Methylphenidate : a treatment for Parkinson's disease?

Authors:  David Devos; Caroline Moreau; Arnaud Delval; Kathy Dujardin; Luc Defebvre; Regis Bordet
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

Review 4.  Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.

Authors:  Cristina Politi; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Neuromolecular Med       Date:  2018-01-05       Impact factor: 3.843

5.  Evaluation of levodopa and carbidopa antioxidant activity in normal human lymphocytes in vitro: implication for oxidative stress in Parkinson's disease.

Authors:  Monica Colamartino; Massimo Santoro; Guglielmo Duranti; Stefania Sabatini; Roberta Ceci; Antonella Testa; Luca Padua; Renata Cozzi
Journal:  Neurotox Res       Date:  2014-10-30       Impact factor: 3.911

Review 6.  Motor Complications of Dopaminergic Medications in Parkinson's Disease.

Authors:  Maria Eliza Freitas; Christopher W Hess; Susan H Fox
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

7.  Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice.

Authors:  L Li; F-M Zhou
Journal:  Neuroscience       Date:  2013-01-26       Impact factor: 3.590

8.  Quantitative autoradiographic study on receptor regulation in the basal ganglia in rat model of levodopa-induced motor complications.

Authors:  Yan Xu; Zhentao Zhang; Kairong Qin; Stella M Papa; Xuebing Cao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

9.  Nutritional status in Parkinson's disease patients undergoing deep brain stimulation surgery: a pilot study.

Authors:  J M Sheard; S Ash; P A Silburn; G K Kerr
Journal:  J Nutr Health Aging       Date:  2013-02       Impact factor: 4.075

10.  Visuomotor adaptation in Parkinson's disease: effects of perturbation type and medication state.

Authors:  Jennifer A Semrau; Joel S Perlmutter; Kurt A Thoroughman
Journal:  J Neurophysiol       Date:  2014-04-02       Impact factor: 2.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.